Publications by authors named "Benjamin Weide"

Claim this Profile
C
Correlation of Baseline Tumor Burden with Clinical Outcome in Melanoma Patients Treated with Ipilimumab.
Daniela Angelova-Toshkina, Benjamin Weide, Lutz F Tietze, Michelle Hebst, Julia K Tietze

Oncology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Putative Cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells and but are also Present in Benign Differentiated Cells.
Lisa Speigl, Nicole Janssen, Benjamin Weide, Tobias Sinnberg, Graham Pawelec

Front Biosci (Landmark Ed)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment.
Markus Haake, Beatrice Haack, Tina Schäfer, Patrick N Harter, Greta Mattavelli, Benjamin Weide

Nat Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma.
Andrea Gaißler, Jonas Bochem, Janine Spreuer, Shannon Ottmann, Alexander Martens, Benjamin Weide

J Immunother Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade.
Andrea Gaißler, Trine Sundebo Meldgaard, Christina Heeke, Sepideh Babaei, Siri Amanda Tvingsholm, Benjamin Weide

Front Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis.
Simone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, Andrea Forschner, Meredith McKean, Benjamin Weide

Eur J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy.
Jonas Bochem, Henning Zelba, Janine Spreuer, Teresa Amaral, Nikolaus B Wagner, Benjamin Weide

J Immunother Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study.
Nikolaus B Wagner, Max M Lenders, Kathrin Kühl, Lydia Reinhardt, Fiona André, Benjamin Weide

J Immunother Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive F-FDG-PET.
Johannes Schwenck, Barbara Schörg, Francesco Fiz, Dominik Sonanini, Andrea Forschner, Benjamin Weide

Theranostics· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Signatures and Survival of Patients With Metastatic Melanoma, Renal Cancer, and Breast Cancer.
Kilian Wistuba-Hamprecht, Cécile Gouttefangeas, Benjamin Weide, Graham Pawelec

Front Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors.
Johanna Winter, Max M Lenders, Maximilian Gassenmaier, Andrea Forschner, Ulrike Leiter, Benjamin Weide

Cancer Immunol Immunother· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors.
Maximilian Gassenmaier, Max M Lenders, Andrea Forschner, Ulrike Leiter, Benjamin Weide

Target Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.
Roberta Turiello, Mariaelena Capone, Diana Giannarelli, Elva Morretta, Maria Chiara Monti, Benjamin Weide

J Immunother Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a link between very early changes of primary and secondary lymphoid organs in F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?
Ferdinand Seith, Andrea Forschner, Benjamin Weide, Brigitte Gückel, Martin Schwartz

J Immunother Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.
David Liu, Bastian Schilling, Derek Liu, Antje Sucker, Elisabeth Livingstone, Benjamin Weide

Nat Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatofluoroscopy diagnostics in different pigmented skin lesions: Strengths and weaknesses.
Maja Ann Hofmann, Ulrike Keim, Agata Jagoda, Andrea Forschner, Christine Fink, Benjamin Weide

J Dtsch Dermatol Ges· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Maja Ann Hofmann, Ulrike Keim, Agata Jagoda, Andrea Forschner, Christine Fink, Benjamin Weide

J Dtsch Dermatol Ges· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitfalls in the characterization of circulating and tissue-resident human γδ T cells.
Nicola Beucke, Daniela Wesch, Hans-Heinrich Oberg, Christian Peters, Jonas Bochem, Benjamin Weide

J Leukoc Biol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG.
Sarah Knispel, Andreas Stang, Lisa Zimmer, Hildegard Lax, Ralf Gutzmer, Benjamin Weide

J Immunother Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade.
Jonas Bochem, Henning Zelba, Teresa Amaral, Janine Spreuer, Daniel Soffel, Benjamin Weide

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.
David Liu, Bastian Schilling, Derek Liu, Antje Sucker, Elisabeth Livingstone, Benjamin Weide

Nat Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
Nikolaus B Wagner, Benjamin Weide, Mirko Gries, Maike Reith, Kathrin Tarnanidis

J Immunother Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer.
Hans-Georg Rammensee, Karl-Heinz Wiesmüller, P Anoop Chandran, Henning Zelba, Elisa Rusch, Benjamin Weide

J Immunother Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tumor-resident mast cells for effective anti-melanoma immune responses.
Susanne Kaesler, Florian Wölbing, Wolfgang Eberhard Kempf, Yuliya Skabytska, Martin Köberle, Benjamin Weide

JCI Insight· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.
Benjamin Weide, Thomas Eigentler, Chiara Catania, Paolo Antonio Ascierto, Stefano Cascinu

Cancer Immunol Immunother· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis